Phyto Chem's ₹6.22 cr insolvency claim is bigger than its entire market cap
The nano-cap's net loss widened to ₹1.80 cr on a 36% revenue fall. A creditor claim against an insolvent debtor now dwarfs the company's equity.
— 1 earlier story on Phyto Chem (India) Ltd. →What's new
- Net loss for FY26 widened to ₹1.80 crore from ₹0.99 crore in FY25.
- Revenue from operations fell 36% to ₹9.07 crore from ₹14.08 crore.
- The company filed a ₹6.22 crore claim against Siri Smelters & Energy, now in NCLT insolvency.
Why this matters
The core business is shrinking and bleeding money. The larger risk is the ₹6.22 crore claim against an insolvent debtor, which is 52% of the company's ₹12 crore market cap and 68% of its annual revenue. Any write-down here would cripple an already weak balance sheet.
What we're watching
- Outcome of the NCLT insolvency resolution for Siri Smelters & Energy.
- The court-appointed professional's reconciliation of the ₹6.22 cr claim.
- Whether revenue stabilises after the 36% collapse this fiscal year.
The full read
Phyto Chem's FY26 results are a story of two problems. First, the operating business is shrinking fast: revenue fell 36% to ₹9.07 crore, and the net loss grew from ₹0.99 crore to ₹1.80 crore. Second, the company has a large, at-risk asset. It has filed a ₹6.22 crore operational claim against Siri Smelters & Energy, which is now in NCLT insolvency. That claim alone is 52% of Phyto Chem's ₹12 crore market cap and 68% of its annual revenue. For a nano-cap already bleeding cash, the recovery on this claim is the single biggest swing factor on the balance sheet. The court-appointed professional is reconciling the amount, but any haircut directly hits an entity that cannot cover its own costs.
Questions answered
- How does the insolvency claim compare to Phyto Chem's size?
- The ₹6.22 crore claim is 52% of the company's ₹12 crore market cap and 68% of its ₹9.07 crore annual revenue. It is a disproportionately large exposure for a nano-cap.
- What is the current status of the claim?
- Siri Smelters was admitted to NCLT insolvency in February 2026. Phyto Chem's claim as an operational creditor is now being reconciled by the court-appointed professional.
- Why did the net loss widen?
- The loss deepened to ₹1.80 crore from ₹0.99 crore as revenue from operations fell 36% to ₹9.07 crore. The filing does not provide a detailed cost breakdown.
- What is the core business risk beyond the claim?
- The operating business contracted sharply. A 36% revenue decline to ₹9.07 crore is a severe deterioration, and the company remains unprofitable.
Story so far
All notes on PHYTO →- 29 May 2026 · 7:52 PM IST Phyto Chem's ₹6.22 cr insolvency claim is bigger than its entire market cap
- 1d ago Phyto Chem okays FY26 results, eyes rental income from factory space